The discovery of S/GSK1265744: a carbamoyl pyridone HIV-1 integrase inhibitor

被引：0

作者：

Taoda, Y. ^{[1
]}

Johns, B. ^{[2
]}

Weatherhead, J. ^{[2
]}

Temelkoff, D. ^{[2
]}

Kawasuji, T. ^{[1
]}

Yoshida, H. ^{[1
]}

Taishi, T. ^{[1
]}

Kiyama, R. ^{[1
]}

Fuji, M. ^{[1
]}

Murai, H. ^{[1
]}

Yoshinaga, T. ^{[1
]}

Sato, A. ^{[1
]}

Fujiwara, T. ^{[1
]}

机构：

[1] Shionogi & Co Ltd, Osaka, Japan

[2] GlaxoSmithKline, Res Triangle Pk, NC USA

来源：

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2012年 / 15卷

关键词：

D O I：

10.7448/IAS.15.6.18267

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：122 / 122

页数：1

共 50 条

[1] Carbamoyl Pyridone HIV-1 Integrase Inhibitors 3. A Diastereomeric Approach to Chiral Nonracemic Tricyclic Ring Systems and the Discovery of Dolutegravir (S/GSK1349572) and (S/GSK1265744)
Johns, Brian A.
Kawasuji, Takashi
Weatherhead, Jason G.
Taishi, Teruhiko
Temelkoff, David P.
Yoshida, Hiroshi
Akiyama, Toshiyuki
Taoda, Yoshiyuki
Murai, Hitoshi
Kiyama, Ryuichi
Fuji, Masahiro
Tanimoto, Norihiko
Jeffrey, Jerry
Foster, Scott A.
Yoshinaga, Tomokazu
Seki, Takahiro
Kobayashi, Masanori
Sato, Akihiko
Johnson, Matthew N.
Garvey, Edward P.
Fujiwara, Tamio
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (14) : 5901 - 5916
[2] Effects of Etravirine on the Pharmacokinetics of the Integrase Inhibitor S/GSK1265744
Ford, Susan L.
Gould, Elizabeth
Chen, Shuguang
Lou, Yu
Dumont, Etienne
Spreen, William
Piscitelli, Stephen
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (01) : 277 - 280
[3] An Efficient and Highly Diastereoselective Synthesis of GSK1265744, a Potent HIV Integrase Inhibitor
Wang, Huan
Kowalski, Matthew D.
Lakdawala, Ami S.
Vogt, Frederick G.
Wu, Lianming
ORGANIC LETTERS, 2015, 17 (03) : 564 - 567
[4] Pharmacokinetics, Safety, and Monotherapy Antiviral Activity of GSK1265744, an HIV Integrase Strand Transfer Inhibitor
Spreen, W.
Min, S.
Ford, S. L.
Chen, S.
Lou, Y.
Bomar, M.
St Clair, M.
Piscitelli, S.
Fujiwara, T.
HIV CLINICAL TRIALS, 2013, 14 (05): : 192 - 203
[5] Antiviral Characteristics of GSK1265744, an HIV Integrase Inhibitor Dosed Orally or by Long-Acting Injection
Yoshinaga, Tomokazu
Kobayashi, Masanori
Seki, Takahiro
Miki, Shigeru
Wakasa-Morimoto, Chiaki
Suyama-Kagitani, Akemi
Kawauchi-Miki, Shinobu
Taishi, Teruhiko
Kawasuji, Takashi
Johns, Brian A.
Underwood, Mark R.
Garvey, Edward P.
Sato, Akihiko
Fujiwara, Tamio
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (01) : 397 - 406
[6] GSK1265744 Demonstrates Robust In Vitro Activity Against Various Clades of HIV-1
Karmon, Sharon L.
Mohri, Hiroshi
Spreen, William
Markowitz, Martin
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 68 (03) : e39 - e41
[7] Lack of Pharmacokinetic Interaction between Rilpivirine and Integrase Inhibitors Dolutegravir and GSK1265744
Ford, Susan L.
Gould, Elizabeth
Chen, Shuguang
Margolis, David
Spreen, William
Crauwels, Herta
Piscitelli, Stephen
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (11) : 5472 - 5477
[8] Advanced mechanistic studies of GSK1265744, a new HIV integrase inhibitor (INI) dosed by oral administration or long-acting parenteral injection
Yoshinaga, T.
Kobayashi, M.
Seki, T.
Wakasa-Morimoto, C.
Kawasuji, T.
Taishi, T.
Sato, A.
Fujiwara, T.
Johns, B.
Underwood, M.
ANTIVIRAL THERAPY, 2013, 18 : A30 - A30
[9] Discovery and Preclinical Profiling of GSK3839919, a Potent HIV-1 Allosteric Integrase Inhibitor
Parcella, Kyle
Wang, Tao
Eastman, Kyle
Zhang, Zhongxing
Yin, Zhiwei
Patel, Manoj
Tu, Yong
Zheng, Barbara Zhizhen
Walker, Michael A.
Saulnier, Mark G.
Frennesson, David
Bowsher, Michael
Gillis, Eric
Peese, Kevin
Belema, Makonen
Cianci, Christopher
Dicker, Ira B.
McAuli, Brian
Ding, Bo
Falk, Paul
Simmermacher, Jean
Parker, Dawn D.
Sivaprakasam, Prasanna
Kish, Kevin
Lewis, Hal
Hanumegowda, Umesh
Jenkins, Susan
Kadow, John F.
Krystal, Mark
Meanwell, Nicholas A.
Naidu, B. Narasimhulu
ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (06): : 972 - 980
[10] HIV-1 integrase inhibitor
Lloyd, AW
DRUG DISCOVERY TODAY, 1996, 1 (04) : 170 - 170

← 1 2 3 4 5 →